
https://civic.readthedocs.io/en/latest/model/evidence/type.html#evidence-type

|   Evidence    | 中文|解释|
| ----------- | ----------- |-----------|
|Predictive | 预测 |有关分子谱对 治疗 反应的影响的证据
|Diagnostic | 诊断 |与分子谱对患者 诊断 的影响有关的证据
|Prognostic|预后|与分子谱对疾病进展、严重程度或患者生存的影响有关的证据
|Predisposing|诱发|证据与种系分子谱在赋予疾病易感性方面的作用有关（包括致病性评估）
|Oncogenic|致癌|证据与体细胞分子谱参与肿瘤发病机制有关，如癌症标志所描述的那样
|Functional|功能的|证据与分子谱对基因产物（例如蛋白质）功能的影响有关

https://civic.readthedocs.io/en/latest/model/evidence/significance.html#evidence-significance

证据类型为Predictive（预测）时
(用药治疗，与突变关系，用这部分即可)
| Significance         | Definition                                                           |
|----------------------|----------------------------------------------------------------------|
| Sensitivity/Response | Associated with a clinical or preclinical response to treatment      |
| Reduced Sensitivity  | Response to treatment is lower than seen in other treatment contexts |
| Resistance           | Associated with clinical or preclinical resistance to treatment      |
| Adverse Response     | Associated with an adverse response to drug treatment                |
| N/A                  | Variant does not inform clinical interepretation                     |

证据类型为Diagnostic（诊断）时

| Significance | Definition                                      |
|--------------|-------------------------------------------------|
| Positive     | Associated with diagnosis of disease or subtype |
| Negative     | Associated with lack of disease or subtype      |

证据类型为Prognostic (预后) 时
| Significance   | Definition                                         |
|----------------|----------------------------------------------------|
| Better Outcome | Demonstrates better than expected clinical outcome |
| Poor Outcome   | Demonstrates worse than expected clinical outcome  |
| N/A            | Variant does not inform clinical action            |

证据类型为Predisposing（诱发） 时

| Significance   | Definition                                                                               |
|----------------|------------------------------------------------------------------------------------------|
| Predisposition | Evidence may contribute to an interpretation of pathogenic/benign at the assertion level |
| Protectiveness | Presence of a germline molecular profile reduces the chance of cancer                    |

证据类型为Oncogenic（致癌） 时

| Significance   | Definition                                                                               |
|----------------|------------------------------------------------------------------------------------------|
| Oncogenicity   | Evidence may contributes to an interpretation of oncogenic/benign at the assertion level |
| Protectiveness | Presence of a somatic molecular profile reduces the chance of cancer                     |

